Widower backs new pancreatic cancer breath trial
Briefly

Widower backs new pancreatic cancer breath trial
"If there had been a breath test, perhaps that would have been performed when she first presented with symptoms - she may have been eligible for treatment, at least giving her more time,"
"Jen thought she had time and had planned things to do for the kids. We had no idea how little time we had left with her."
"Jen had so many different tests: blood tests, scans, endoscopies, but it didn't pick up the cancer," Mr Palmer said. "She was diagnosed too late and was too physically weak for chemotherapy to have given her more time. "
"The brutality of the disease can't be understated, there are no options at late stages - there must be hope for those who will go through this in the future."
Andrew Palmer’s wife Jen, 50, was diagnosed with pancreatic cancer in February 2024 and died a month later after symptoms went undetected by existing tests. Pancreatic Cancer UK invested more than £1.1m to develop a breath test that identifies volatile organic compounds (VOCs) present in cancer patients, including early-stage disease. The project will become a multi-centre validation study aiming for NHS adoption. The trial plans to recruit over 6,000 patients from the NHS Urgent Suspected Cancer Pathway across about 40 hospital sites in England, Scotland and Wales. The trial aims to enable earlier diagnosis and treatment.
Read at www.bbc.com
Unable to calculate read time
[
|
]